<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">helmholtzeyeinstitute</journal-id><journal-title-group><journal-title xml:lang="ru">Российский офтальмологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Ophthalmological Journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2072-0076</issn><issn pub-type="epub">2587-5760</issn><publisher><publisher-name>Real time Publishers</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21516/2072-0076-2018-11-3-5-10</article-id><article-id custom-type="elpub" pub-id-type="custom">helmholtzeyeinstitute-163</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group></article-categories><title-group><article-title>РОЛЬ БРАХИТЕРАПИИ В ЛЕЧЕНИИ КАПИЛЛЯРНЫХ ГЕМАНГИОМ СЕТЧАТКИ</article-title><trans-title-group xml:lang="en"><trans-title>THE ROLE OF BRACHYTHERAPY IN THE TREATMENT OF RETINAL CAPILLARY HEMANGIOMAS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нероев</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Neroev</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Саакян</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Saakyan</surname><given-names>S. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Илюхин</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Ilyukhin</surname><given-names>P. A.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вальский</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Valskiy</surname><given-names>V. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Рябина</surname><given-names>М. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ryabina</surname><given-names>M. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Новикова</surname><given-names>А. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Novikova</surname><given-names>A. Yu.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБУ "Московский НИИ глазных болезней им. Гельмгольца" Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Moscow Helmholtz Research Institute of Eye Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>03</day><month>10</month><year>2018</year></pub-date><volume>11</volume><issue>3</issue><fpage>5</fpage><lpage>10</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Нероев В.В., Саакян С.В., Илюхин П.А., Вальский В.В., Рябина М.В., Новикова А.Ю., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Нероев В.В., Саакян С.В., Илюхин П.А., Вальский В.В., Рябина М.В., Новикова А.Ю.</copyright-holder><copyright-holder xml:lang="en">Neroev V.V., Saakyan S.V., Ilyukhin P.A., Valskiy V.V., Ryabina M.V., Novikova A.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://roj.igb.ru/jour/article/view/163">https://roj.igb.ru/jour/article/view/163</self-uri><abstract><p>Ru офтальмоаппликаторы. В 7 глазах до брахитерапии проводилась лазерная коагуляция. Сроки наблюдения после локального облучения составили от 1 месяца до 3 лет. Результаты. Стабилизация патологического процесса достигнута в 13 глазах. В сроки до 3 мес. в 5 глазах развилась выраженная лучевая реакция, тотальная отслойка сетчатки, рецидивирующий гемофтальм, что через 6 мес. и более привело к развитию неоваскулярной глаукомы. Энуклеация выполнена в 1 случае в связи с терминальной болящей глаукомой. В 3 глазах при регрессии опухоли отслойка сетчатки без захвата макулярной зоны сохранялась на протяжении всего периода наблюдения. В сроки до 2 лет наблюдались осложненная катаракта (12 глаз), нейроретинопатия (2 глаза), появление новых капиллярных гемангиом (1 глаз), усиление эпиретинального фиброза (4 глаза), вторичная центральная хориоретинальная дистрофия (2 глаза). Заключение. Применение метода БТ в лечении КГ сетчатки позволяет в большинстве случаев добиться удовлетворительного анатомического результата. Однако с целью снижения послеоперационных осложнений, а также повышения уровня функционального результата необходимо проводить тщательный предоперационный отбор пациентов с учетом исходного ретинального статуса. Для цитирования: Нероев В.В., Саакян С.В., Илюхин П.А., Вальский В.В., Рябина М.В., Новикова А.Ю. Роль брахитерапии в лечении капиллярных гемангиом сетчатки. Российский офтальмологический журнал. 2018; 11(3):5-10. doi: 10.21516/2072-0076-2018-11-3-5-10</p></abstract><trans-abstract xml:lang="en"><p>Purpose: to evaluate the efficiency of brachytherapy treatment in capillary retinal hemangioma and the emerging complications. Material and methods. Between 2005 and 2014, 18 patients with capillary hemangioma of the retina (11 females and 7 males, mean age 29 ± 13.9 years) were treated, 8 patients had monocular and 10 patients had binocular lesion. In 12 cases, capillary hemangioma of the retina was associated with Hippel - Lindau disease, in 6 cases a sporadic tumor appeared. 90Sr and 106Ru ophthalmic applicators were used. In 7 eyes, brachytherapy was preceded by laser coagulation. After local irradiation, the patients were followed up for 1 month to 3 years. Results. The pathological process was stabilized in 13 eyes. 5 eyes, no later than 3 months after the procedure, developed a severe radiation reaction, total retinal detachment, and recurrent hemophthalmos, which later, after 6 months or more, led to the development of neovascular glaucoma. In one case, the eye had to be enucleated due to terminal painful glaucoma. In 3 eyes despite tumor regression, retinal detachment persisted over the follow-up period, although the macular area remained unaffected. Complicated cataract (12 eyes), neuroretinopathy (2 eyes), appearance of new capillary hemangiomas (1 eye), increased epiretinal fibrosis (4 eyes), and secondary central chorioretinal dystrophy (2 eyes) were observed over the period of up to 2 years. Conclusion. In most cases, brachytherapy of retinal capillary brings about a satisfactory anatomical result. However, in order to reduce postoperative complications and improve the functional result, a thorough preoperative selection of patients is needed, which should take into account the initial retinal status. For citation: Neroev V.V., Saakyan S.V., Ilyukhin P.A., Valskiy V.V., Ryabina M.V., Novikova A.Yu. The role of brachytherapy in the treatment of retinal capillary hemangiomas. Russian ophthalmological journal. 2018; 11 (3): 5-10 (In Russian). doi: 10.21516/2072-0076-2018-11-3-5-10</p></trans-abstract><kwd-group xml:lang="ru"><kwd>капиллярная гемангиома сетчатки</kwd><kwd>болезнь Гиппеля-Линдау</kwd><kwd>брахитерапия</kwd><kwd>отслойка сетчатки</kwd><kwd>retinal capillary hemangioma</kwd><kwd>von Hippel - Lindau disease</kwd><kwd>brachytherapy</kwd><kwd>retinal detachment</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Sanfilippo P., Troutbeck R., Vandeleur K. Retinal angioma associated with von Hippel-Lindau disease. Clinical and Experimental Optometry. 2003; 86: 187-191. doi:10.1111/j.1444-0938.2003.tb03102.x</mixed-citation><mixed-citation xml:lang="en">Sanfilippo P., Troutbeck R., Vandeleur K. Retinal angioma associated with von Hippel-Lindau disease. Clinical and Experimental Optometry. 2003; 86: 187-191. doi:10.1111/j.1444-0938.2003.tb03102.x</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Latif F., Tory K., Gnarra J., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993; 260: 1317-20. doi:10.1126/science.8493574</mixed-citation><mixed-citation xml:lang="en">Latif F., Tory K., Gnarra J., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science. 1993; 260: 1317-20. doi:10.1126/science.8493574</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Singh A.D., Shields C.L., Shields J.A. von Hippel-Lindau disease. Surv. Ophthalmol. 2001; 46 (2): 117-42. https://doi.org/10.1016/S0039-6257(01)00245-4</mixed-citation><mixed-citation xml:lang="en">Singh A.D., Shields C.L., Shields J.A. von Hippel-Lindau disease. Surv. Ophthalmol. 2001; 46 (2): 117-42. https://doi.org/10.1016/S0039-6257(01)00245-4</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Chew E.Y. Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations. Trans. Am. Ophthalmol. Soc. 2005; 103: 495-511.</mixed-citation><mixed-citation xml:lang="en">Chew E.Y. Ocular manifestations of von Hippel-Lindau disease: clinical and genetic investigations. Trans. Am. Ophthalmol. Soc. 2005; 103: 495-511.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Lonser R.R., Glenn G.M., Walther M. et al. von Hippel-Lindau disease. Lancet. 2003; 361 (9374): 2059-67. https://doi.org/10.1016/S0140-6736(03)13643-4</mixed-citation><mixed-citation xml:lang="en">Lonser R.R., Glenn G.M., Walther M. et al. von Hippel-Lindau disease. Lancet. 2003; 361 (9374): 2059-67. https://doi.org/10.1016/S0140-6736(03)13643-4</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Webster A.R., Maher E.R., Moore A.T. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germ line mutation. Arch. Ophthalmol. 1999; 117(3): 371-8. doi:10.1001/archopht.117.3.371</mixed-citation><mixed-citation xml:lang="en">Webster A.R., Maher E.R., Moore A.T. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germ line mutation. Arch. Ophthalmol. 1999; 117(3): 371-8. doi:10.1001/archopht.117.3.371</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Chan C.C., Chew E.Y., Shen D., Hackett J., Zhuang Z. Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease. Mol Vis. 2005; 11: 697-704.</mixed-citation><mixed-citation xml:lang="en">Chan C.C., Chew E.Y., Shen D., Hackett J., Zhuang Z. Expression of stem cells markers in ocular hemangioblastoma associated with von Hippel-Lindau (VHL) disease. Mol Vis. 2005; 11: 697-704.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Neumann H.P., Wiestler O.D. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet. 1991; 337 (8749): 1052-54. https://doi.org/10.1016/0140-6736(91)91705-Y</mixed-citation><mixed-citation xml:lang="en">Neumann H.P., Wiestler O.D. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet. 1991; 337 (8749): 1052-54. https://doi.org/10.1016/0140-6736(91)91705-Y</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Webster A.R., Maher E.R., Bird A.C., Gregor Z.J., Moore A.T. A clinical and molecular genetic analysis of solitary ocular angioma. Ophthalmology 1999; 106 (3): 623-9. https://doi.org/10.1016/S0161-6420(99)90127-6</mixed-citation><mixed-citation xml:lang="en">Webster A.R., Maher E.R., Bird A.C., Gregor Z.J., Moore A.T. A clinical and molecular genetic analysis of solitary ocular angioma. Ophthalmology 1999; 106 (3): 623-9. https://doi.org/10.1016/S0161-6420(99)90127-6</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Huang C., Tian Z., Lai K. et al. Long-term therapeutic outcomes of photodynamic therapy-based or photocoagulation-based treatments on retinal capillary hemangioma. Photomed. Laser Surg. 2018; 36(1): 10-7. doi:10.1089/pho.2017.4296</mixed-citation><mixed-citation xml:lang="en">Huang C., Tian Z., Lai K. et al. Long-term therapeutic outcomes of photodynamic therapy-based or photocoagulation-based treatments on retinal capillary hemangioma. Photomed. Laser Surg. 2018; 36(1): 10-7. doi:10.1089/pho.2017.4296</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Koen S-I., Kvintel' G. Fluorescence angiography in the diagnosis of fundus pathology. Neroev V.V., Ryabina M.V., eds. Moscow: Reytar; 2005. (in Russian).</mixed-citation><mixed-citation xml:lang="en">Koen S-I., Kvintel' G. Fluorescence angiography in the diagnosis of fundus pathology. Neroev V.V., Ryabina M.V., eds. Moscow: Reytar; 2005. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Singh A.D., Nouri M., Shields C.L. et al. Treatment of retinal capillary hemangioma. Ophthalmology. 2002; 109: 1799-806. http://dx.doi.org/10.1016/S0161-6420(02)01177-6</mixed-citation><mixed-citation xml:lang="en">Singh A.D., Nouri M., Shields C.L. et al. Treatment of retinal capillary hemangioma. Ophthalmology. 2002; 109: 1799-806. http://dx.doi.org/10.1016/S0161-6420(02)01177-6</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Suh C.S., Jin S.Y., Bae S.H., Kim C.G., Kim J.W. Retinal capillary hemangioma treated with verteporfin photodynamic therapy and intravitreal triamcinolone acetonide. Korean J. Ophthalmol. 2007; 21(3): 178-84. https://doi.org/10.3341/kjo.2007.21.3.178</mixed-citation><mixed-citation xml:lang="en">Suh C.S., Jin S.Y., Bae S.H., Kim C.G., Kim J.W. Retinal capillary hemangioma treated with verteporfin photodynamic therapy and intravitreal triamcinolone acetonide. Korean J. Ophthalmol. 2007; 21(3): 178-84. https://doi.org/10.3341/kjo.2007.21.3.178</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Gauthier D., D’Amico D.J., Mukai S. von Hippel-Lindau disease. Int. Ophthalmol. Clin. 2001; 41: 173-87.</mixed-citation><mixed-citation xml:lang="en">Gauthier D., D’Amico D.J., Mukai S. von Hippel-Lindau disease. Int. Ophthalmol. Clin. 2001; 41: 173-87.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Schmidt D., Natt E., Neumann H.P. Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. Eur. J. Med. Res. 2000; 5(2): 47-58.</mixed-citation><mixed-citation xml:lang="en">Schmidt D., Natt E., Neumann H.P. Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. Eur. J. Med. Res. 2000; 5(2): 47-58.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Blodi C.F., Russell S.R., Pulido J.S., Folk J.C. Direct and feeder vessel photocoagulation of retinal angiomas with dye yellow laser. Ophthalmology. 1990; 97(6): 791-7. doi:10.1016/S0161-6420(90)32509-5</mixed-citation><mixed-citation xml:lang="en">Blodi C.F., Russell S.R., Pulido J.S., Folk J.C. Direct and feeder vessel photocoagulation of retinal angiomas with dye yellow laser. Ophthalmology. 1990; 97(6): 791-7. doi:10.1016/S0161-6420(90)32509-5</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kreusel K.M., Bornfeld N., Lommatzsch A., Wessing A., Foerster M.H. Ruthenium-106 brachytherapy for pe ripheral retinal capillary hemangiomas. Ophthalmology. 1998; 105(8): 1386-92. https://doi.org/10.1016/S0161-6420(98)98017-4</mixed-citation><mixed-citation xml:lang="en">Kreusel K.M., Bornfeld N., Lommatzsch A., Wessing A., Foerster M.H. Ruthenium-106 brachytherapy for pe ripheral retinal capillary hemangiomas. Ophthalmology. 1998; 105(8): 1386-92. https://doi.org/10.1016/S0161-6420(98)98017-4</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Саакян С.В., Пантелеева О.Г., Ширина Т.В. Оценка выживаемости больных увеальной меланомой после органосохранного лечения и энуклеации. Российский офтальмологический журнал. 2011; 4(1): 67-70.</mixed-citation><mixed-citation xml:lang="en">Саакян С.В., Пантелеева О.Г., Ширина Т.В. Оценка выживаемости больных увеальной меланомой после органосохранного лечения и энуклеации. Российский офтальмологический журнал. 2011; 4(1): 67-70.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Stannard C., Sauerwein W., Maree G., Lecuona K. Radiotherapy for ocular tumors. Eye. 2013; 27(2): 119-27.</mixed-citation><mixed-citation xml:lang="en">Stannard C., Sauerwein W., Maree G., Lecuona K. Radiotherapy for ocular tumors. Eye. 2013; 27(2): 119-27.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Shields C.L., Shields J.A., Cater J. et al. Plaque radiotherapy for uveal melanoma: long - term visual outcome in 1106 consecutive patients. Arch. Ophthalmol. 2000; 118: 1219-28. doi:10.1001/archopht.118.9.1219</mixed-citation><mixed-citation xml:lang="en">Shields C.L., Shields J.A., Cater J. et al. Plaque radiotherapy for uveal melanoma: long - term visual outcome in 1106 consecutive patients. Arch. Ophthalmol. 2000; 118: 1219-28. doi:10.1001/archopht.118.9.1219</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Shields C.L., Shields J.A., De Potter P. et al. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment. Ophthalmology. 1993; 100(2): 216-24. https://doi.org/10.1016/S0161-6420(93)31667-2</mixed-citation><mixed-citation xml:lang="en">Shields C.L., Shields J.A., De Potter P. et al. Plaque radiotherapy in the management of retinoblastoma. Use as a primary and secondary treatment. Ophthalmology. 1993; 100(2): 216-24. https://doi.org/10.1016/S0161-6420(93)31667-2</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Anastassiou G., Bornfeld N., Schueler A.O. et al. Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina. Br. J. Ophthalmol. 2006; 90(4): 447-50. https://doi.org/10.1136/bjo.2005.081422</mixed-citation><mixed-citation xml:lang="en">Anastassiou G., Bornfeld N., Schueler A.O. et al. Ruthenium-106 plaque brachytherapy for symptomatic vasoproliferative tumours of the retina. Br. J. Ophthalmol. 2006; 90(4): 447-50. https://doi.org/10.1136/bjo.2005.081422</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Turaka K., Turaka A., Koneru B.N. Role of radiation therapy for choroidal hemangioma: a brief review. J. Clin. Res. Ophthalmol. 2016; 3(1): 18-22. doi: 10.17352/2455-1414.000030</mixed-citation><mixed-citation xml:lang="en">Turaka K., Turaka A., Koneru B.N. Role of radiation therapy for choroidal hemangioma: a brief review. J. Clin. Res. Ophthalmol. 2016; 3(1): 18-22. doi: 10.17352/2455-1414.000030</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kreusel K.M., Bornfeld N., Lommatzsch A., Wessing A., Foerster M.H. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology. 1998; 105(8): 1386-92. https://doi.org/10.1016/S0161-6420(98)98017-4</mixed-citation><mixed-citation xml:lang="en">Kreusel K.M., Bornfeld N., Lommatzsch A., Wessing A., Foerster M.H. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology. 1998; 105(8): 1386-92. https://doi.org/10.1016/S0161-6420(98)98017-4</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Russo V., Stella A., Barone A., Scott I.U., Noci N.D. Ruthenium-106 brachytherapy and intravitreal bevacizumab for retinal capillary hemangioma. Int Ophthalmol. 2012; 32(1): 71-5. doi: 10.1007/s10792-011-9513-1</mixed-citation><mixed-citation xml:lang="en">Russo V., Stella A., Barone A., Scott I.U., Noci N.D. Ruthenium-106 brachytherapy and intravitreal bevacizumab for retinal capillary hemangioma. Int Ophthalmol. 2012; 32(1): 71-5. doi: 10.1007/s10792-011-9513-1</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Balázs E., Berta A., Rózsa L., Kolozsvári L., Rigó G. Hemodynamic changes after Ruthenium irradiation of Hippel's angiomatosis. Ophthalmologica. 1990; 200: 128-132. doi: 10.1159/000310093</mixed-citation><mixed-citation xml:lang="en">Balázs E., Berta A., Rózsa L., Kolozsvári L., Rigó G. Hemodynamic changes after Ruthenium irradiation of Hippel's angiomatosis. Ophthalmologica. 1990; 200: 128-132. doi: 10.1159/000310093</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Grossniklaus H.E., Thomas J.W., Vignesavaran N., Jarrett W.H. Retinal hemangioblastoma: a histologic, immunohistochemical, and ultrastructural evaluation. Ophthalmology 1992; 99 (1): 140-145. https://doi.org/10.1016/S0161-6420(92)32024-X</mixed-citation><mixed-citation xml:lang="en">Grossniklaus H.E., Thomas J.W., Vignesavaran N., Jarrett W.H. Retinal hemangioblastoma: a histologic, immunohistochemical, and ultrastructural evaluation. Ophthalmology 1992; 99 (1): 140-145. https://doi.org/10.1016/S0161-6420(92)32024-X</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
